16 employees
Nuage Therapeutics engages in developing drugs which target proteins in disordered regions for challenging indications faced by patients.
2021
$13M
from 3 investors over 3 rounds
Nuage Therapeutics raised $13M on March 14, 2023
Investors: Asabys Partners, CDTI, Centre for the Development of Industrial Technology and Sofinnova Partners